The effect of hyperbaric oxygenation on the in vitro growth of Escherichia coli in environments with and without blood cells

Annals of Microbiology

Volumn 56, Issue 1, 2006, Pages 77-79

  Ardic, Nurittin ^a   Yildiz, Senol ^a   Cimsit, Maide ^b   Turhan, Vedat ^a   Ozyurt, Mustafa ^a   Haznederoglu, Tuncer ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Escherichia coli; Hyperbaric oxygenation; In vitro growth; Microbial colony count

Indexed keywords

ESCHERICHIA COLI;

EID: 33645689185     PISSN: 15904261     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03174974     Document Type: Article

References (24)

1. Allen D.B., Maguire J.J., Mahdavian M., Wicke C., Marcocci L., Scheuenstuhl H., Chang M., Le A.X., Hopf H.W., Hunt T.K. (1997). Wound hypoxia and acidosis limit neutrophil bacterial killing mechanisms. Arch. Surg., 132: 991-996.
2. Barriere C., Bruckner R., Talon R. (2001). Characterization of the single superoxide dismutase of Staphylococcus xylosus. Appl. Environ. Microbiol., 67: 4096-4104.
3. Bornside G.H., Pakman L.M., Ordonez A.A. (1975). Inhibition of pathogenic enteric bacteria by hyperbaric oxygen: Enhanced antibacterial activity in the absence of carbon dioxide. Antimicrob. Agents Chemother., 7: 982-987.
4. Brown O.R., Smyk-Randall E., Draczynska-Lusiak B., Fee J.A. (1995). Dihydroxy-acid dehydratase, a [4Fe-4S] cluster-containing enzyme in Escherichia coli: effects of intracellular superoxide dismutase on its inactivation by oxidant stress. Arch. Biochem. Biophys., 319: 10-22.
5. Brown O.R. (1990). Mechanisms of hyperbaric-oxygen inhibition of growth and net biosynthesis of RNA, DNA, protein and lipids in Escherichia coli. Microbios, 64: 135-151.
6. Caldwell P., Luk D.A., Weissbach H., Broth N. (1978). Oxidation of methionine residues of Escherichia coli: Ribosomal protein L 12 decreases the protein's biological activity. Proc. Natl. Acad. Sci., 75: 956-958.
7. Doctor N., Pandya S., Supe A. (1992). Hyperbaric oxygen therapy in diabetic foot. J. Postgrad. Med., 38: 112-114.
8. Etlik O., Tomur A., Dundar K., Erdem A., Gundogan N.U. (1997). The effect of antioxidant vitamins E and C on lipoperoxidation of erythrocyte membranes during hyperbaric oxygenation. J. Basic. Clin. Physiol. Pharmacol., 8: 269-277.
9. th edn., ASM Press, Washington, D.C.
10. Farr S.B., Touati D., Kogoma T. (1988). Effects of oxygen stress on membrane functions in Escherichia coli: Role of HPI catalase. J. Bacteriol., 170: 1837-1842.
11. Flint D.H., Smyk-Randall E., Tuminello J.F., Draczynska-Lusiak B., Brown O.R. (1993). The inactivation of dihydroxy-acid dehydratase in Escherichia coli treated with hyperbaric oxygen occurs because of the destruction of its Fe-S cluster, but the enzyme remains in the cell in a form that can be reactivated. J. Biol. Chem., 268: 25547-25552.
12. Godfrey R.W., Wilder M.S. (1985). Generation of oxygen species and virulence of Listeria monocytogenes. Infect. Immun., 47: 837-839.
13. Gregory E.M., Fridovich I. (1973). Oxygen toxicity and the superoxide dismutase. J. Bacteriol., 114: 1193-1197.
14. Halliwell B. (1978) Biochemical mechanisms accounting for the toxic action of oxygen on living organisms: the key role of superoxide dismutase. Cell. Biol. Int. Rep., 2: 113-128.
15. Jain K.K. (2004). HBO Therapy in infections. In: Jain K.K., Ed., Textbook of Hyperbaric Medicine. Hogrefe & Huber Pub., U.S.A., pp. 133-145.
16. Luongo C., Imperatore F., Matera M.G., Mangoni G., Marmo M., Baroni A., Catalanotti P., Rossi F., Filippelli A. (1999). Effect of hyperbaric oxygen therapy in experimental subcutaneous and pulmonary infections due to Pseudomonas aeruginosa. Undersea Hyperb. Med., 26: 21-25.
17. Mader J.T., Brown G.L., Guckian J.C., Wells C.H., Reinarz J.A. (1980). A mechanism for the amelioration by hyperbaric oxygen of experimental staphylococcal osteomyelitis in rabbits. J. Infect. Dis., 142: 915-922.
18. Moody C.S., Hassan H.M. (1982). Mutagenicity of oxygen free radicals. Proc. Natl. Acad. Sci., 79: 2855-2859.
19. Muhvich K.H., Park M.K., Myers R.A., Marzella L. (1989). Hyperoxia and the antimicrobial susceptibility of Escherichia coli and Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 33: 1526-1530.
20. nd edn. revised, Best Publishing Company, U.S.A., pp. 205-243.
21. Pezzlo M. (1992). Initial processing, inoculation, and incubation of aerobic bacteriology specimens. In: Isenberg H.D., Ed., Clinical Microbiology Procedures Handbook, Vol. 1, ASM Press, U.S.A., pp. 14-21.
22. Stephens M.B. (1996). Gas gangrene: potential for hyperbaric oxygen therapy. Postgrad. Med., 99: 217-224.
23. Sugihara A., Watanabe H., Oohashi M., Kato N., Murakami H., Tsukazaki S., Fujikawa K. (2004). The effect of hyperbaric oxygen therapy on the bout of treatment for soft tissue infections. J. Infect., 48: 330-333.
24. rd., Kanmura Y., Fujimoto T. (2001). Hyperbaric hyperoxia suppress growth of Staphylococcus aureus, including methicilline-resistant strains. J. Anest., 15: 29-32.